Dave Kappos as Next PTO Director?

pic-26.jpgAlthough the Obama administration has not directly asked my opinion, I would certainly support David Kappos as the nominee for the next PTO director. Kappos is a longtime IBM patent guru and currently holds the title of VP and Assistant General Counsel in charge of Intellectual Property.

Bottom line here is that it will be helpful to have a patent office director who understands patents and who has been fully involved with all aspects of the patent system for the past twenty years. I believe that Kappos will be a careful shepherd of the system - leaving it better off in six years than it is today.

Kappos believes in the underlying value of innovation. In his words, "the whole system of innovation is more important now than ... ever." Beyond that, he is dedicated to a strong patent system and a strong patent office as mechanisms for fostering innovation. Kappos has been ready to try innovative approaches to "catch the intellectual property system up to the twenty first century." However, he has always been clear that his ideas for innovation "should in no way be confused with denigration or devaluing intellectual property." In addition, his years at IBM have taught him the value of consistency and tradition.

Much of the job of PTO director involves employee relations, and Kappos continues to successfully lead one of the largest private patent departments in the world. His current and former employees are loyal to him as a leader and praise his creativity and genius. The IBM IP office is known for its spirited and open debates on policy and direction. In my view, this corporate management experience and patent prosecution experience are more relevant to running the PTO than - say - running litigation teams at a law firm, managing a congressional committee, or even teaching a group of law students. Before moving forward, I want to note here that former Director Todd Dickinson is also an excellent choice, and he continues to be strongly supported by both examiners and other patent law professionals. Dickinson would almost certainly do the better job of healing the growing rift between examiners and applicants.

In his recent testimony to the Senate, Kappos put IBM's support behind the compromise form of the Patent Reform Act. For IBM, it was important that the damages portion of the bill be revised: "we must nevertheless be mindful of the fundamental importance of ensuring that patentees are appropriately compensated or the patent system will fail to provide the incentive innovators require." However, the IBM proposal was that royalties should be based on the "essential features" of a patent. (Quoting Quanta). This proposal is problematic because it would create new-rule uncertainty and also greatly favor holders of large patent portfolios (such as IBM). As director, Kappos should be careful to balance the "right" solution with the need for consistency and stability of rights. IBM also supported the post-grant review system (which I favor) and the venue changes (which I do not favor).

More than his alignment on specific provisions, we can hope that Kappos will bring an important amount of subject matter expertise - helping to ensure that any legislation does not inadvertently disrupt parts of the system that are already working well.

I do have other reservations. Patent pundit Greg Aharonian has oft complained about Kappos and his tendency to talk about patent quality and then charge forward with junky IBM patent applications. Those complaints have merit. The ill defined term 'patent quality' raises red flags in my mind. Here, Kappos has his benign and potentially helpful pet projects of dramatically improving examiner's access (and ease of access) to prior art; improving prior art and patent documents through more standard lexicons; and public collaboration in patent examination (IBM funded the peer to patent program). In the past, Kappos has talked about patent quality as a problem because it leads to a situation where "nobody has an earthly idea of what [a patent] is worth . . . creating a murky and unclear market." These are really proposals to make the prosecution system work more efficiently rather any fundamental changes to patent rights. IBM is good at systems, and Kappos may be as well.

If it is a benefit, it is also a fault that Kappos' blood is saturated with IBM knowledge and culture. Kappos joined IBM in 1983 right out of college (EE / UC Davis) and stayed with the company after law school (Berkeley). At IBM he spent time with the software legal division and also in the Asia/Pacific division. Unfortunately, in the past 25 years, Kappos may have forgotten that most of the world does not operate like IBM. Thus, when he says that "people no longer innovate individually" or that "many new innovations require investments of unprecedented size," I worry that his vision is skewed. Beyond the PTO, IBM has been able to use its large portfolio and market power to build a large licensing pool with very little litigation. Of course, there are few companies in a position to accomplish that result in today's market. It will be important for him to spend time understanding that - in fact - IBM is the atypical market player. On these point, I believe that Kappos will relax his views somewhat once he is no longer the AGC of IBM.

I am excited that Kappos will push the PTO toward a more open system - allowing access to data and information that has been hidden or limited and ready to cooperate on collaborative projects to streamline the system. Kappos has considerable experience with both European and Asian patent systems, and will likely expand cross-border examination collaboration.

On the software side, Kappos will continue to support the idea that software should be patentable - although he argues that patents should at least cover something "technological" and that business methods should be out. Kappos has also spent a lot of time thinking and working with overlapping intellectual property schemes and considering how those interplay with open source software. However, I have not seen any specific proposals.

In the Patently-O reader poll, Kappos earned only 5% of the vote, falling behind Todd Dickinson (36%), Prof Lemley (8%), and "other" (8%).

Other Sources:

  • Why Kappos is Unfit
  • IP Watchdog on Kappos
  • From Greg Aharonian:
  • "One rumored candidate to be the next Director of the Patent and Trademark Office is David Kappos, one of the head patent lawyers at IBM. Given IBM's many abuses of the patent system and patent policy over the past few decades, I think it is inappropriate, nay, wrong, for anyone from IBM to be head of the PTO. Might as well as make Bernie Madoff head of the SEC as part of his upcoming jail-time work-release program. IBM patent lawyers for too long have abused the patent system."
  • "Case in point. Last week IBM was issued its usual batch of patents, many of which are crap - crappy patents whose sole value is to clog the PTO's patent examination pipelines to the detriment of everyone else. A patent application policy actively embraced by David Kappos. If I was an IBM investor, I would applaud David for doing his best to help IBM. In fact, sometimes I recommend people to buy IBM stock because the company will do anything to maintain its market value. Kudos to David for his efforts in this regard. But the reward for abusing the patent system for the benefit of IBM should be a gold watch at retirement - and should not be the reward of being appointed head of the PTO."

Bits and Bytes NO. 88

  • New PTO Director: The USPTO will be closed on Monday and Tuesday (Jan. 19-20). When it reopens, John Doll will be the Acting Director of the USPTO. Doll is a career PTO official and already fully understands the system and the role of the PTO director. Because Doll has had considerable influence while working under Jon Dudas, we can expect that there will be few immediate or dramatic changes. In part because of the absence of a Commerce Secretary, I expect that Doll's tenure will likely last for several months.
  • Secretary of Commerce: While on the topic, I heard this morning that John Thompson, CEO of Symantec may be named appointed as the next Secretary of Commerce. If appointed, Thompson may play an important role in some patentability disputes. Symantec has been directly involved in a number of patent litigation disputes – both as a plaintiff and as a defendant. Symantec is the assignee of hundreds of patents. I cannot say, however, whether Thompson feels scorned or empowered by the current patent system.
  • Chief Judge Michel & Professor Lichtman: Professor Doug Lichtman has introduced his most recent guest on the "IP Colloquium" – Chief Judge Paul Michel of the Court of Appeals for the Federal Circuit. In an hour-long discussion, the pair discuss common deficiencies in appellate advocacy; the important value of amicus briefs at the rehearing stage; Section 101 post-Bilski; and the lost doctrine of equivalents. Professor Lichtman has configured the system so that you can also easily claim free CLE credit in California, Illinois, NY, Texas, or Washington State. Excellent work!
  • ABA Top Legal Blogs: For two years in a row, the ABA Journal has chosen Patently-O as one of the top 100 legal blogs. (Only 50 blogs made the cut both years). In addition, Patently-O has been honored in 2008 as the top legal blog focusing on a niche area of law. Thank you to everyone who voted during this process! In time for Patently-O's fifth anniversary in April, I expect that the website will record its ten-millionth visit in addition to the 16,000+ readers who receive their updates via the daily e-mail feed.
  • Patent agent Brian Galvin has started a new blog, in a recent post, he discusses the BPAI's Cornea-Hasegan Opinion. His analogy is interesting: "[The current state] of statutory eligibility … reminds me of … Ptolemaic astronomy just before Galileo, Kepler and Copernicus. The more wheels we add, the more untenable the whole structure." [LINK]

Inherent Anticipation at the Supreme Court

AIPLATalk209SmithKline Beecham v. Apotex (on petition for writ of certiorari)

The Supreme Court is contemplating hearing this case that questions the standards for inherent anticipation ScreenShot030of a patent. The drug in question is Paxil, and the case history has more twists than a Hazzard County road. But, the question now before the Court is simple:

Whether a compound that is inevitably produced by the prior art is inherently anticipated by the prior art, and thus not novel under 35 U.S.C. 102.

Another way to focus on the particular question is whether any human recognition of the inherency is required.

Here, Paxil (a PHC hemihydrate) is inevitably produced by a PHC anhydrate, and PHC anhydrate (A.K.A. Ferrosan) was well known before the Paxil patent.

Judge Posner (sitting by designation) determined that Paxil was not inherently anticipated because its inevitable production from Ferrosan was not a “scientific []certainty.” On appeal, the CAFC reversed that particular decision — finding that the patent was inherently anticipated because PHC hemihydrate “inevitably results from production of” PHC anhydrate.

Now, the Solicitor General has provided the government’s views on the case, and supported the CAFC decision:

The court of appeals correctly held that the patent claim is invalid because PHC hemihydrate was inherently anticipated by the prior art that inevitably produced it. . . . a characteristic of a pre-existing product is not patentable even if no one had previously recognized that characteristic.

Because the Gov’t fully supports the CAFC decision, it also recommended against hearing the case.

Submit a Patent Job Opening [OLD]

This is a job board for patent law professionals. Employers pay a small fee to post ads. Job seekers pay nothing.

Patently-O Jobs will be available on this site and through the Patently-O Blog. The Patently-O network includes a daily readership of 30,000+ patent professionals and had well over three-million web visits in the past year (in addition to e-mail and RSS subscribers). Many of the nation’s top law firms, corporations, and government agencies have continued to post their patent positions with us and find top candidates for nearly ten years now.

Pricing: A 30-day job listing costs $200. After submitting the form, you will be redirected to a page to submit payment online. If you have any questions, please contact us at jobs@patentlyo.com before submitting.

Submit a patent job
Note: Form will open in a new window.

Renewals: Want to extend a current listing for a second (or third) month? You can do this for just $100 by submitting our renewal form. Be sure to have the URL of your listing handy. This does not apply to older listings or listings with content changes.

Note: We monitor submissions daily and will usually post listings within about one business day of receiving them.

We can’t share a preview of the listing prior to posting it, but we will email you with a link to the listing when it is live. At that point you can share any edits/feedback/etc. if you have it.

Submit a Patent Job Opening

This is a job board for patent law professionals. Employers pay a small fee to post ads. Job seekers pay nothing.

Patently-O Jobs will be available on this site and through the Patently-O Blog. The Patently-O network includes a daily readership of 30,000+ patent professionals and had well over three-million web visits in the past year (in addition to e-mail and RSS subscribers). Many of the nation’s top law firms, corporations, and government agencies have continued to post their patent positions with us and find top candidates for nearly ten years now.

Pricing: A 30-day job listing costs $200. After submitting the form, you will be redirected to a page to submit payment online. If you have any questions, please contact us at jobs@patentlyo.com before submitting.

Submit a patent job
Note: Form will open in a new window.

Renewals: Want to extend a current listing for a second (or third) month? You can do this for just $100 by submitting our renewal form. Be sure to have the URL of your listing handy. This does not apply to older listings or listings with content changes.

Note: We monitor submissions daily and will usually post listings within about one business day of receiving them.

We can’t share a preview of the listing prior to posting it, but we will email you with a link to the listing when it is live. At that point you can share any edits/feedback/etc. if you have it.

Patently-O Blog: Terms of Use and Disclaimer

Updated September 6, 2024

These Terms of Use are a binding contract between you and Patently-O LLC (PO). They contain the rules and restrictions that govern your use of Patently-O products and services (referred to below simply as “Patently-O”). If you have any questions, comments, or concerns regarding these Terms, please contact us at dcrouch@patentlyo.com.

If you’re agreeing to these Terms on behalf of an organization, you represent that you are authorized to agree to these Terms on behalf of that organization and bind them to these Terms (in which case, the references to “you” and “your” throughout this document refer to that organization or entity).

The particular terms of use are simple:

  • We are providing you with access to the Patently-O blog, regularly hosted at https://patentlyo.com/.
  • No Warranties: This site is provided on an “as is” and “as available” basis. While we endeavor to keep everything correct and running smoothly, it will not always happen.  PO and Dennis Crouch particularly disclaim all warranties, including merchantability and fitness.
  • Posting Content: If you post content (typically via guest post or comments), do not violate anyone else’s rights.
  • Limited License: By posting content, you provide PO with a fully paid up perpetual license to copy, display, rework and distribute the content in various forms.  You still own any copyright to your content.
  • Scraping: You agree not to allow or cause any robotic scraping of the site without express permission from PO
  • Copyright: The material here is copyrighted. As a subscriber, you have the right to access the content.  You can also distribute short snippets or, occasionally, entire posts, to non-subscribers.  However, you may not post the content online or share it widely without written permission from PO. Our main concern here is that we don’t want to undermine the subscription setup.
  • Filtering: As a general matter, Patently-O often tries to make reasonable and good faith attempts to remove content that we deem problematic. However, our filters are far from perfect. PO does not accept any responsibility for poor filtering.  If there is content that needs removed, please contact us and we will likely pull it from the site.
  • No Sharing Accounts: Each subscriber is an individual, and you are not permitted to share your account with others because that undermines the subscription model.
  • Limitation on Liability: To the fullest extent allowed by applicable law, under no circumstances and under no legal theory shall PO or Dennis Crouch be liable to you or to any other person for any damages of any kind in any amount greater than the great of (1) $100 and (2) the amount you paid to us in connection with the prior 12 months subscription.

Patent Applications After Final Rejection: A One-Year Follow-Up Study

by Dennis Crouch

I have been looking at after final practice, and potential changes going forward in how applicant's respond to this important decision point.

The chart above looks at fate of patent applications that received final rejections in January 2024 -- and shows an optimistic picture one-year out. Among the 15,813 applications tracked, nearly half (48%) have issued as patents or at least received a notice of allowance, suggesting that a final rejection, while a significant hurdle, is far from the end of the road for many applications. And, that an allowance may well be on the horizon. A substantial percentage of these cases used the now defunct After Final Consideration Pilot (AFCP 2.0) to transform the rejection into allowance.  Moving forward, applicants will likely instead need to file a Request for Continued Examination (RCE) or appeal.


To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.

Thorner and the (Not So) Bright Line Rules of Claim Construction

by Dennis Crouch

The Federal Circuit’s 2012 decision in Thorner v. Sony Computer Entertainment America LLC, 669 F.3d 1362 (Fed. Cir. 2012) has become one of the court’s most cited cases from the past 15 years.  In fact, the decision has over 9,000 citations since being released 12 years ago (according to Westlaw search).  The case did not really make new ground, but is most often cited for Judge Moore’s statement of the clear boundaries for when courts can permissibly deviate from the “plain and ordinary meaning” of claim terms. While the decision presents these as bright-line rules, I would argue that the reality is much more nuanced. (more…)